The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, whose array of ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Roche said Tuesday it plans to invest $50 billion in the U.S. over the next five years, creating more than 12,000 new jobs in ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Roche will invest $50 billion over the next five years for new research and development sites across the US, including a new manufacturing facility in Indiana.

Also, various other major tech firms have announced investments on U.S. soil this year, including Apple's $500 billion for manufacturing and training, TSMC's $100 billion for chip making, and Nvidia's ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

Roche to invest $50 billion in U.S. over five years, adding 12,000+ jobs and expanding manufacturing, R&D, and export capacity across eight states.